Role of the cGAS-STING pathway in cancer development and oncotherapeutic approaches

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is crucial for innate immunity against microbes.
• This pathway can be activated by self-DNA in tumors, impacting cancer development.
• Dysregulation of the cGAS-STING pathway is implicated in various cancers.

Purpose of the Study:

• To review and discuss the dual roles of the cGAS-STING pathway in cancer.
• To explore therapeutic strategies targeting the cGAS-STING pathway in cancer treatment.
• To examine the potential of oncolytic virus therapy in cancers with deficient cGAS-STING signaling.

Main Methods:

• Literature review of studies on the cGAS-STING pathway in cancer.
• Analysis of research on STING agonists and their combination therapies.
• Evaluation of oncolytic virus therapy in the context of cGAS-STING pathway deficiency.

Main Results:

• The cGAS-STING pathway exhibits dichotomous effects, promoting or inhibiting tumor growth.
• STING agonists are being developed as cancer therapeutics, alone or in combination.
• Oncolytic virus therapy shows promise for cancers lacking functional cGAS-STING signaling.

Conclusions:

• The cGAS-STING pathway is a critical regulator in cancer immunity and development.
• Targeting the cGAS-STING pathway offers promising therapeutic avenues for cancer treatment.
• Understanding cGAS-STING pathway status is essential for selecting appropriate cancer therapies.